KR20010071827A
(ko)
*
|
1998-07-10 |
2001-07-31 |
앤더슨 데릭 제이. |
반점성망막 퇴행에서 신혈관 신생의 예방치료
|
JP2002541975A
(ja)
|
1999-04-26 |
2002-12-10 |
ジーエムピー ヴィジョン ソルーションズ インコーポレイテッド |
緑内障の治療のための線維柱帯切開装置および方法
|
US6416777B1
(en)
*
|
1999-10-21 |
2002-07-09 |
Alcon Universal Ltd. |
Ophthalmic drug delivery device
|
PT1221917E
(pt)
*
|
1999-10-21 |
2005-04-29 |
Alcon Inc |
Dispositivo para ministrar medicamentos
|
US7943162B2
(en)
|
1999-10-21 |
2011-05-17 |
Alcon, Inc. |
Drug delivery device
|
US20050119737A1
(en)
*
|
2000-01-12 |
2005-06-02 |
Bene Eric A. |
Ocular implant and methods for making and using same
|
US6638239B1
(en)
|
2000-04-14 |
2003-10-28 |
Glaukos Corporation |
Apparatus and method for treating glaucoma
|
US7867186B2
(en)
|
2002-04-08 |
2011-01-11 |
Glaukos Corporation |
Devices and methods for treatment of ocular disorders
|
US7708711B2
(en)
|
2000-04-14 |
2010-05-04 |
Glaukos Corporation |
Ocular implant with therapeutic agents and methods thereof
|
US20020143284A1
(en)
*
|
2001-04-03 |
2002-10-03 |
Hosheng Tu |
Drug-releasing trabecular implant for glaucoma treatment
|
AR030345A1
(es)
*
|
2000-08-14 |
2003-08-20 |
Alcon Inc |
Metodo de tratamiento de desordenes relacionados con angiogenesis
|
JP2004517674A
(ja)
*
|
2000-12-29 |
2004-06-17 |
ボシュ・アンド・ロム・インコーポレイテッド |
徐放薬物送達装置
|
US6756058B2
(en)
|
2001-01-03 |
2004-06-29 |
Bausch & Lomb Incorporated |
Sustained release drug delivery devices with multiple agents
|
EP1347742A1
(en)
*
|
2001-01-03 |
2003-10-01 |
Bausch & Lomb Incorporated |
Sustained release drug delivery devices with prefabricated permeable plugs
|
CA2433528A1
(en)
*
|
2001-01-26 |
2002-08-01 |
Bausch & Lomb Incorporated |
Improved process for the production of sustained release drug delivery devices
|
AU2002258754B2
(en)
|
2001-04-07 |
2006-08-17 |
Glaukos Corporation |
Glaucoma stent and methods thereof for glaucoma treatment
|
US7488303B1
(en)
*
|
2002-09-21 |
2009-02-10 |
Glaukos Corporation |
Ocular implant with anchor and multiple openings
|
US7431710B2
(en)
|
2002-04-08 |
2008-10-07 |
Glaukos Corporation |
Ocular implants with anchors and methods thereof
|
US7678065B2
(en)
|
2001-05-02 |
2010-03-16 |
Glaukos Corporation |
Implant with intraocular pressure sensor for glaucoma treatment
|
US7094225B2
(en)
|
2001-05-03 |
2006-08-22 |
Glaukos Corporation |
Medical device and methods of use of glaucoma treatment
|
US7563255B2
(en)
*
|
2001-05-03 |
2009-07-21 |
Massachusetts Eye And Ear Infirmary |
Implantable drug delivery device and use thereof
|
EP1404297B1
(en)
|
2001-06-12 |
2011-04-27 |
The Johns Hopkins University School Of Medicine |
Reservoir device for intraocular drug delivery
|
EP1385452B1
(en)
*
|
2001-07-23 |
2006-09-13 |
Alcon, Inc. |
Ophthalmic drug delivery device
|
WO2003009774A2
(en)
*
|
2001-07-23 |
2003-02-06 |
Alcon, Inc. |
Ophthalmic drug delivery device
|
US7331984B2
(en)
|
2001-08-28 |
2008-02-19 |
Glaukos Corporation |
Glaucoma stent for treating glaucoma and methods of use
|
US7749528B2
(en)
*
|
2001-08-29 |
2010-07-06 |
Ricardo Azevedo Pontes De Carvalho |
Implantable and sealable medical device for unidirectional delivery of therapeutic agents to tissues
|
CN1578647B
(zh)
*
|
2001-08-29 |
2010-04-07 |
里卡多·A·P·德卡瓦尔霍 |
一种用于单向传送药剂到目标组织的可以手术植入的及可密封的装置
|
US20060034929A1
(en)
*
|
2001-12-27 |
2006-02-16 |
Brubaker Michael J |
Sustained release drug delivery devices with prefabricated permeable plugs
|
US7186232B1
(en)
|
2002-03-07 |
2007-03-06 |
Glaukoa Corporation |
Fluid infusion methods for glaucoma treatment
|
US7951155B2
(en)
|
2002-03-15 |
2011-05-31 |
Glaukos Corporation |
Combined treatment for cataract and glaucoma treatment
|
US9301875B2
(en)
|
2002-04-08 |
2016-04-05 |
Glaukos Corporation |
Ocular disorder treatment implants with multiple opening
|
US20070265582A1
(en)
*
|
2002-06-12 |
2007-11-15 |
University Of Southern California |
Injection Devices for Unimpeded Target Location Testing
|
US20030233126A1
(en)
*
|
2002-06-12 |
2003-12-18 |
Alfred E. Mann Institute For Biomedical Engineering |
Injection devices and methods for testing implants
|
WO2004012742A1
(en)
*
|
2002-08-05 |
2004-02-12 |
Alcon, Inc. |
Use of anecortave acetate for the protection of visual acuity in patients with age related macular degeneration
|
DE10238310A1
(de)
*
|
2002-08-21 |
2004-03-04 |
Erich Jaeger Gmbh |
Elektrodenanordnung
|
WO2004028477A2
(en)
*
|
2002-09-29 |
2004-04-08 |
Surmodics, Inc. |
Methods for treatment and/or prevention of retinal disease
|
WO2004073551A2
(en)
*
|
2003-02-18 |
2004-09-02 |
Massachusetts Eye And Ear Infirmary |
Transscleral drug delivery device and related methods
|
US20060154910A1
(en)
*
|
2003-02-20 |
2006-07-13 |
Bingaman David P |
Use of steroids to treat ocular disorders
|
ZA200505990B
(en)
*
|
2003-02-20 |
2006-12-27 |
Alcon Inc |
Formulations of glucocorticoids to treat pathologic ocular angiogenesis
|
US20050261668A1
(en)
*
|
2003-03-28 |
2005-11-24 |
Bausch & Lomb Incorporated |
Drug delivery device
|
US20040236343A1
(en)
*
|
2003-05-23 |
2004-11-25 |
Taylor Jon B. |
Insertion tool for ocular implant and method for using same
|
MXPA05012696A
(es)
*
|
2003-06-13 |
2006-02-22 |
Alcon Inc |
Formulaciones de agentes antiinflamatorios no esteroides para tratar angiogenesis ocular patologica.
|
US20070059381A1
(en)
*
|
2003-06-20 |
2007-03-15 |
Barker Ronnie C |
Treatment of amd with combination of ingredients
|
US20040265356A1
(en)
*
|
2003-06-30 |
2004-12-30 |
Bausch & Lomb Incorporated |
Drug delivery device
|
AU2004258857A1
(en)
*
|
2003-07-10 |
2005-02-03 |
Alcon, Inc. |
Ophthalmic drug delivery device
|
JP4869930B2
(ja)
|
2003-08-26 |
2012-02-08 |
ヴィスタ サイエンティフィック エルエルシー |
眼科薬物供給装置
|
NZ617083A
(en)
*
|
2003-08-27 |
2015-04-24 |
Ophthotech Corp |
Combination therapy for the treatment of ocular neovascular disorders
|
EP1682132A1
(en)
*
|
2003-09-18 |
2006-07-26 |
Macusight, Inc. |
Transscleral delivery
|
US20050158365A1
(en)
*
|
2003-12-22 |
2005-07-21 |
David Watson |
Drug delivery device with mechanical locking mechanism
|
US20050136095A1
(en)
*
|
2003-12-22 |
2005-06-23 |
Brian Levy |
Drug delivery device with suture ring
|
US7276050B2
(en)
*
|
2004-03-02 |
2007-10-02 |
Alan Franklin |
Trans-scleral drug delivery method and apparatus
|
WO2005105133A2
(en)
*
|
2004-04-23 |
2005-11-10 |
Massachusetts Eye And Ear Infirmary |
Methods and compositions for preserving the viability of photoreceptor cells
|
US8673341B2
(en)
*
|
2004-04-30 |
2014-03-18 |
Allergan, Inc. |
Intraocular pressure reduction with intracameral bimatoprost implants
|
US20060182781A1
(en)
*
|
2004-04-30 |
2006-08-17 |
Allergan, Inc. |
Methods for treating ocular conditions with cyclic lipid contraining microparticles
|
US9498457B2
(en)
|
2004-04-30 |
2016-11-22 |
Allergan, Inc. |
Hypotensive prostamide-containing biodegradable intraocular implants and related implants
|
US7993634B2
(en)
|
2004-04-30 |
2011-08-09 |
Allergan, Inc. |
Oil-in-oil emulsified polymeric implants containing a hypotensive lipid and related methods
|
US7799336B2
(en)
|
2004-04-30 |
2010-09-21 |
Allergan, Inc. |
Hypotensive lipid-containing biodegradable intraocular implants and related methods
|
US7589057B2
(en)
|
2004-04-30 |
2009-09-15 |
Allergan, Inc. |
Oil-in-water method for making alpha-2 agonist polymeric drug delivery systems
|
US8722097B2
(en)
*
|
2004-04-30 |
2014-05-13 |
Allergan, Inc. |
Oil-in-water method for making polymeric implants containing a hypotensive lipid
|
WO2006002366A2
(en)
*
|
2004-06-24 |
2006-01-05 |
Surmodics, Inc. |
Biodegradable ocular devices, methods and systems
|
WO2006014484A2
(en)
|
2004-07-02 |
2006-02-09 |
Surmodics, Inc. |
Methods and devices for the treatment of ocular conditions
|
WO2006039459A1
(en)
*
|
2004-09-30 |
2006-04-13 |
Bausch & Lomb Incorporated |
Capsule for encasing tablets for surgical insertion into the human body
|
US20060134162A1
(en)
*
|
2004-12-16 |
2006-06-22 |
Larson Christopher W |
Methods for fabricating a drug delivery device
|
US20060134176A1
(en)
*
|
2004-12-22 |
2006-06-22 |
Bausch & Lomb Incorporated |
Pharmaceutical delivery system and method of use
|
US8663639B2
(en)
|
2005-02-09 |
2014-03-04 |
Santen Pharmaceutical Co., Ltd. |
Formulations for treating ocular diseases and conditions
|
AU2006213673A1
(en)
|
2005-02-09 |
2006-08-17 |
Santen Pharmaceutical Co., Ltd. |
Formulations for ocular treatment
|
CN101180086A
(zh)
*
|
2005-04-08 |
2008-05-14 |
苏尔莫迪克斯公司 |
用于经视网膜下递送的持续释放植入物
|
CN103169714A
(zh)
*
|
2005-07-12 |
2013-06-26 |
Dmi生物科学公司 |
治疗疾病的方法和产品
|
US20070100199A1
(en)
*
|
2005-11-03 |
2007-05-03 |
Lilip Lau |
Apparatus and method of delivering biomaterial to the heart
|
US20070212397A1
(en)
*
|
2005-09-15 |
2007-09-13 |
Roth Daniel B |
Pharmaceutical delivery device and method for providing ocular treatment
|
US20070134244A1
(en)
*
|
2005-10-14 |
2007-06-14 |
Alcon, Inc. |
Combination treatment for pathologic ocular angiogenesis
|
CA2635797C
(en)
|
2006-02-09 |
2015-03-31 |
Macusight, Inc. |
Stable formulations, and methods of their preparation and use
|
JP5506378B2
(ja)
|
2006-03-23 |
2014-05-28 |
参天製薬株式会社 |
血管透過性に関連する疾患または病気のための製剤および方法
|
RU2413480C2
(ru)
*
|
2006-03-31 |
2011-03-10 |
Клт Плаг Диливери, Инк. |
Способы доставки лекарственных средств, структуры и композиции для носослезной системы
|
US20070293807A1
(en)
*
|
2006-05-01 |
2007-12-20 |
Lynch Mary G |
Dual drainage pathway shunt device and method for treating glaucoma
|
EP2019646A4
(en)
*
|
2006-05-04 |
2013-12-04 |
Herbert Kaufman |
METHOD, DEVICE AND SYSTEM FOR THE RELEASE OF A THERAPEUTIC ACTIVE IN THE EYE
|
US7981096B2
(en)
*
|
2006-05-12 |
2011-07-19 |
David Castillejos |
Optic nerve head implant and medication delivery system
|
SG138567A1
(en)
*
|
2006-06-21 |
2008-01-28 |
Johnson & Johnson Vision Care |
Punctal plugs for the delivery of active agents
|
US20120123316A1
(en)
|
2010-11-15 |
2012-05-17 |
Aquesys, Inc. |
Intraocular shunts for placement in the intra-tenon's space
|
US8663303B2
(en)
|
2010-11-15 |
2014-03-04 |
Aquesys, Inc. |
Methods for deploying an intraocular shunt from a deployment device and into an eye
|
AU2007269259B2
(en)
|
2006-06-30 |
2012-05-31 |
Aquesys Inc. |
Methods, systems and apparatus for relieving pressure in an organ
|
US8852256B2
(en)
|
2010-11-15 |
2014-10-07 |
Aquesys, Inc. |
Methods for intraocular shunt placement
|
US8308701B2
(en)
|
2010-11-15 |
2012-11-13 |
Aquesys, Inc. |
Methods for deploying intraocular shunts
|
US10085884B2
(en)
|
2006-06-30 |
2018-10-02 |
Aquesys, Inc. |
Intraocular devices
|
US8721702B2
(en)
|
2010-11-15 |
2014-05-13 |
Aquesys, Inc. |
Intraocular shunt deployment devices
|
US8506515B2
(en)
|
2006-11-10 |
2013-08-13 |
Glaukos Corporation |
Uveoscleral shunt and methods for implanting same
|
US20100034808A1
(en)
|
2006-11-21 |
2010-02-11 |
Toru Nakazawa |
Compositions and methods for preserving cells of the eye
|
US20080140024A1
(en)
*
|
2006-12-08 |
2008-06-12 |
Yoseph Yaacobi |
Drug delivery device
|
CA2670944A1
(en)
*
|
2006-12-18 |
2008-06-26 |
Alcon Research, Ltd. |
Devices and methods for ophthalmic drug delivery
|
US20080265343A1
(en)
*
|
2007-04-26 |
2008-10-30 |
International Business Machines Corporation |
Field effect transistor with inverted t shaped gate electrode and methods for fabrication thereof
|
EA201170297A1
(ru)
*
|
2008-08-09 |
2011-08-30 |
Массачусетс Инститьют Оф Текнолоджи |
Имплантируемое устройство для доставки лекарственных средств и способ лечения мужской мочеполовой системы и окружающих тканей
|
US20100104654A1
(en)
*
|
2008-10-27 |
2010-04-29 |
Allergan, Inc. |
Prostaglandin and prostamide drug delivery systems and intraocular therapeutic uses thereof
|
US8623395B2
(en)
|
2010-01-29 |
2014-01-07 |
Forsight Vision4, Inc. |
Implantable therapeutic device
|
CN104887389B
(zh)
|
2009-01-29 |
2017-06-23 |
弗赛特影像4股份有限公司 |
后段给药
|
US10206813B2
(en)
|
2009-05-18 |
2019-02-19 |
Dose Medical Corporation |
Implants with controlled drug delivery features and methods of using same
|
EP4108216A1
(en)
|
2009-06-03 |
2022-12-28 |
Forsight Vision5, Inc. |
Anterior segment drug delivery
|
DK2554173T3
(en)
*
|
2009-06-22 |
2017-01-16 |
Ampio Pharmaceuticals Inc |
PROCEDURE FOR DISEASE CARE
|
BRPI1010086A2
(pt)
*
|
2009-06-22 |
2018-02-06 |
Dmi Acquisition Corp |
método e produtos para tratamento de doenças
|
US8529492B2
(en)
|
2009-12-23 |
2013-09-10 |
Trascend Medical, Inc. |
Drug delivery devices and methods
|
US10166142B2
(en)
|
2010-01-29 |
2019-01-01 |
Forsight Vision4, Inc. |
Small molecule delivery with implantable therapeutic device
|
US20130017243A1
(en)
*
|
2010-04-06 |
2013-01-17 |
Allergan, Inc. |
Sustained-release reservoir implants for intracameral drug delivery
|
EP2560629B1
(en)
|
2010-04-23 |
2020-06-03 |
Massachusetts Eye & Ear Infirmary |
Methods and compositions for preserving photoreceptor and retinal pigment epithelial cells
|
JP2013526572A
(ja)
|
2010-05-17 |
2013-06-24 |
アエリエ・ファーマシューティカルズ・インコーポレーテッド |
眼治療薬の送達のための薬物送達装置
|
EP3960134A1
(en)
|
2010-08-05 |
2022-03-02 |
ForSight Vision4, Inc. |
Implantable therapeutic device
|
PT2600930T
(pt)
|
2010-08-05 |
2021-03-22 |
Forsight Vision4 Inc |
Aparelho injetor e método para distribuição de fármacos
|
EP2600876B1
(en)
|
2010-08-05 |
2015-04-29 |
Forsight Vision4, Inc. |
Combined drug delivery methods and apparatus
|
US20120109054A1
(en)
*
|
2010-10-29 |
2012-05-03 |
Vista Scientific Llc |
Devices with an erodible surface for delivering at least one active agent to tissue over a prolonged period of time
|
US20140024598A1
(en)
|
2010-11-01 |
2014-01-23 |
Demetrios Vavvas |
Methods and compositions for preserving retinal ganglion cells
|
US20160256320A1
(en)
|
2010-11-15 |
2016-09-08 |
Aquesys, Inc. |
Intraocular shunt placement in the suprachoroidal space
|
CA2818612C
(en)
|
2010-11-19 |
2020-12-29 |
Forsight Vision4, Inc. |
Therapeutic agent formulations for implanted devices
|
US9107816B2
(en)
*
|
2011-02-04 |
2015-08-18 |
Taris Biomedical Llc |
Implantable device for controlled dissolution and diffusion of low solubility drug
|
US10245178B1
(en)
|
2011-06-07 |
2019-04-02 |
Glaukos Corporation |
Anterior chamber drug-eluting ocular implant
|
WO2013003467A2
(en)
|
2011-06-27 |
2013-01-03 |
Massachusetts Eye And Ear Infirmary |
Methods for treating ocular inflammatory disorders
|
EP4249059A3
(en)
|
2011-06-28 |
2023-11-29 |
ForSight Vision4, Inc. |
An apparatus for collecting a sample of fluid from a reservoir chamber of a therapeutic device for the eye
|
US9724357B2
(en)
|
2011-08-15 |
2017-08-08 |
Massachusetts Eye & Ear Infirmary |
Methods for preserving photoreceptor cell viability following retinal detachment
|
WO2013040238A2
(en)
*
|
2011-09-13 |
2013-03-21 |
Vista Scientific Llc |
Sustained release ocular drug delivery devices and methods of manufacture
|
EP4193907A1
(en)
|
2011-09-13 |
2023-06-14 |
Glaukos Corporation |
Intraocular physiological sensor
|
RU2740680C2
(ru)
|
2011-09-14 |
2021-01-19 |
Форсайт Вижн5, Инк. |
Глазное вкладочное устройство и способы
|
SI2755600T1
(sl)
|
2011-09-16 |
2021-08-31 |
Forsight Vision4, Inc. |
Naprava za izmenjavo tekočine
|
WO2013059791A2
(en)
|
2011-10-21 |
2013-04-25 |
Massachusetts Eye And Ear Infirmary |
Methods and compositions for promoting axon regeneration and nerve function
|
US8852136B2
(en)
*
|
2011-12-08 |
2014-10-07 |
Aquesys, Inc. |
Methods for placing a shunt into the intra-scleral space
|
US8765210B2
(en)
|
2011-12-08 |
2014-07-01 |
Aquesys, Inc. |
Systems and methods for making gelatin shunts
|
US10080682B2
(en)
|
2011-12-08 |
2018-09-25 |
Aquesys, Inc. |
Intrascleral shunt placement
|
US9808373B2
(en)
|
2013-06-28 |
2017-11-07 |
Aquesys, Inc. |
Intraocular shunt implantation
|
US9610195B2
(en)
|
2013-02-27 |
2017-04-04 |
Aquesys, Inc. |
Intraocular shunt implantation methods and devices
|
WO2013116061A1
(en)
|
2012-02-03 |
2013-08-08 |
Forsight Vision4, Inc. |
Insertion and removal methods and apparatus for therapeutic devices
|
EP2708209A1
(en)
*
|
2012-09-13 |
2014-03-19 |
AJL Ophthalmic, S.A. |
Scleral epimacular implant
|
PL2911623T3
(pl)
|
2012-10-26 |
2020-03-31 |
Forsight Vision5, Inc. |
System oczny do przedłużonego uwalniania leku do oka
|
CA2888775C
(en)
*
|
2012-11-01 |
2018-03-20 |
Poway Retinal Technologies, Llc |
Retinal repair device and method
|
EA201500752A1
(ru)
|
2012-12-19 |
2016-05-31 |
Ампио Фармасьютикалс, Инк. |
Способ лечения заболеваний
|
PT2956476T
(pt)
|
2013-02-18 |
2020-02-21 |
Vegenics Pty Ltd |
Moléculas de ligação e usos destas
|
US10159600B2
(en)
|
2013-02-19 |
2018-12-25 |
Aquesys, Inc. |
Adjustable intraocular flow regulation
|
TW201507749A
(zh)
|
2013-03-11 |
2015-03-01 |
Sanofi Aventis Deutschland |
用於藥物輸送裝置之組件
|
US9730638B2
(en)
|
2013-03-13 |
2017-08-15 |
Glaukos Corporation |
Intraocular physiological sensor
|
AU2014236455B2
(en)
|
2013-03-14 |
2018-07-12 |
Forsight Vision4, Inc. |
Systems for sustained intraocular delivery of low solubility compounds from a port delivery system implant
|
US9592151B2
(en)
|
2013-03-15 |
2017-03-14 |
Glaukos Corporation |
Systems and methods for delivering an ocular implant to the suprachoroidal space within an eye
|
ES2972168T3
(es)
|
2013-03-28 |
2024-06-11 |
Forsight Vision4 Inc |
Implante oftálmico para administración de sustancias terapéuticas
|
JP6340673B2
(ja)
*
|
2013-05-02 |
2018-06-13 |
レティナ ファウンデーション オブ ザ サウスウエストRetina Foundation Of The Southwest |
二層型眼用インプラント
|
SG10201912985RA
(en)
|
2013-07-12 |
2020-02-27 |
Ophthotech Corp |
Methods for treating or preventing ophthalmological conditions
|
KR102380245B1
(ko)
|
2013-11-07 |
2022-03-30 |
에디타스 메디신, 인코포레이티드 |
지배적인 gRNA를 이용하는 CRISPR-관련 방법 및 조성물
|
AU2014348536B2
(en)
|
2013-11-14 |
2017-01-12 |
Aquesys, Inc. |
Intraocular shunt inserter
|
EP3089748A4
(en)
|
2014-01-02 |
2017-09-27 |
Massachusetts Eye & Ear Infirmary |
Treating ocular neovascularization
|
WO2015134812A1
(en)
|
2014-03-05 |
2015-09-11 |
Editas Medicine, Inc. |
Crispr/cas-related methods and compositions for treating usher syndrome and retinitis pigmentosa
|
US11339437B2
(en)
|
2014-03-10 |
2022-05-24 |
Editas Medicine, Inc. |
Compositions and methods for treating CEP290-associated disease
|
US11141493B2
(en)
|
2014-03-10 |
2021-10-12 |
Editas Medicine, Inc. |
Compositions and methods for treating CEP290-associated disease
|
EP3553176A1
(en)
|
2014-03-10 |
2019-10-16 |
Editas Medicine, Inc. |
Crispr/cas-related methods and compositions for treating leber's congenital amaurosis 10 (lca10)
|
EP3981876A1
(en)
|
2014-03-26 |
2022-04-13 |
Editas Medicine, Inc. |
Crispr/cas-related methods and compositions for treating sickle cell disease
|
EP3677229A1
(en)
|
2014-05-29 |
2020-07-08 |
Glaukos Corporation |
Implants with controlled drug delivery features
|
MY182497A
(en)
|
2014-07-15 |
2021-01-25 |
Forsight Vision4 Inc |
Ocular implant delivery device and method
|
AU2015301054B2
(en)
|
2014-08-08 |
2020-05-14 |
Forsight Vision4, Inc. |
Stable and soluble formulations of receptor tyrosine kinase inhibitors, and methods of preparation thereof
|
CA2967330A1
(en)
|
2014-11-10 |
2016-05-19 |
Forsight Vision4, Inc. |
Expandable drug delivery devices and methods of use
|
EP3283004A4
(en)
|
2015-04-13 |
2018-12-05 |
Forsight Vision5, Inc. |
Ocular insert composition of semi-crystalline or crystalline pharmaceutically active agent
|
EP3286571B1
(en)
|
2015-04-24 |
2021-08-18 |
Editas Medicine, Inc. |
Evaluation of cas9 molecule/guide rna molecule complexes
|
US10010502B2
(en)
|
2015-05-19 |
2018-07-03 |
Amorphex Therapeutics Llc |
Device that delivers a sustained low-dose of a myopia-suppressing drug, while preserving pupillary function and accommodation
|
CN112998944B
(zh)
|
2015-06-03 |
2023-08-22 |
阿奎西斯公司 |
外路眼内分流器放置
|
WO2017040853A1
(en)
|
2015-09-02 |
2017-03-09 |
Glaukos Corporation |
Drug delivery implants with bi-directional delivery capacity
|
WO2017053885A1
(en)
|
2015-09-25 |
2017-03-30 |
Glaukos Corporation |
Punctal implants with controlled drug delivery features and methods of using same
|
EP3368670A1
(en)
|
2015-10-30 |
2018-09-05 |
Editas Medicine, Inc. |
Crispr/cas-related methods and compositions for treating herpes simplex virus
|
CA3005238A1
(en)
|
2015-11-20 |
2017-05-26 |
Forsight Vision4, Inc. |
Porous structures for extended release drug delivery devices
|
US11512311B2
(en)
|
2016-03-25 |
2022-11-29 |
Editas Medicine, Inc. |
Systems and methods for treating alpha 1-antitrypsin (A1AT) deficiency
|
CA3019822A1
(en)
|
2016-04-05 |
2017-10-12 |
Forsight Vision4, Inc. |
Implantable ocular drug delivery devices
|
JP7003110B2
(ja)
|
2016-04-20 |
2022-01-20 |
ドーズ メディカル コーポレーション |
生体吸収性眼球薬物送達デバイス
|
MX2018014763A
(es)
|
2016-06-02 |
2019-04-29 |
Aquesys Inc |
Suministro intraocular de farmacos.
|
EP3494220A1
(en)
|
2016-08-02 |
2019-06-12 |
Editas Medicine, Inc. |
Compositions and methods for treating cep290 associated disease
|
WO2018034945A1
(en)
|
2016-08-19 |
2018-02-22 |
The United States Of America, As Represented By The Secretary, Department Of Health And Human Services |
Selective estrogen-receptor modulators (serms) confer protection against photoreceptor degeneration
|
WO2018081504A1
(en)
|
2016-10-28 |
2018-05-03 |
Editas Medicine, Inc. |
Crispr/cas-related methods and compositions for treating herpes simplex virus
|
JP2020514407A
(ja)
|
2017-01-24 |
2020-05-21 |
マクリーゲン, インク.Macregen, Inc. |
アポリポプロテイン模倣物を用いる加齢黄斑変性と他の眼疾患の治療
|
CA3054497A1
(en)
|
2017-03-03 |
2018-09-07 |
Macregen, Inc. |
Treatment of age-related macular degeneration and other eye diseases with one or more therapeutic agents
|
EP3596217A1
(en)
|
2017-03-14 |
2020-01-22 |
Editas Medicine, Inc. |
Systems and methods for the treatment of hemoglobinopathies
|
WO2018204848A1
(en)
|
2017-05-05 |
2018-11-08 |
University Of Pittsburgh - Of The Commonwealth System Of Higher Education |
Ocular applications of matrix bound vesicles (mbvs)
|
EP3622070A2
(en)
|
2017-05-10 |
2020-03-18 |
Editas Medicine, Inc. |
Crispr/rna-guided nuclease systems and methods
|
US10905770B2
(en)
|
2017-07-17 |
2021-02-02 |
Macregen, Inc. |
Topical delivery of therapeutic agents using cell-penetrating peptides for the treatment of age-related macular degeneration and other eye diseases
|
US11246753B2
(en)
|
2017-11-08 |
2022-02-15 |
Aquesys, Inc. |
Manually adjustable intraocular flow regulation
|
BR112020010053A2
(pt)
|
2017-11-21 |
2020-11-03 |
Forsight Vision4, Inc. |
aparelho para troca de fluido para sistema de liberação de porta expansível e métodos de uso do mesmo
|
WO2019169291A1
(en)
|
2018-03-02 |
2019-09-06 |
The United States Of America, As Represented By The Secretary, Department Of Health And Human Services |
Use of il-34 to treat retinal inflammation and neurodegeneration
|
US10952898B2
(en)
|
2018-03-09 |
2021-03-23 |
Aquesys, Inc. |
Intraocular shunt inserter
|
US11135089B2
(en)
|
2018-03-09 |
2021-10-05 |
Aquesys, Inc. |
Intraocular shunt inserter
|
WO2020176552A1
(en)
|
2019-02-25 |
2020-09-03 |
Editas Medicine, Inc. |
Crispr/rna-guided nuclease-related methods and compositions for treating rho-associated autosomal-dominant retinitis pigmentosa (adrp)
|
EP4090381A1
(en)
|
2020-01-17 |
2022-11-23 |
The United States of America, as represented by the Secretary, Department of Health and Human Services |
<smallcaps/>? ? ?crx-? ? ? ? ?gene therapy for treatment ofautosomal dominant retinopathies
|
US20230301984A1
(en)
|
2020-07-02 |
2023-09-28 |
The Usa, As Represented By The Secretary, Department Of Health And Human Services |
Cyclic compounds for use in treating retinal degeneration
|
EP4323522A1
(en)
|
2021-04-16 |
2024-02-21 |
Editas Medicine, Inc. |
Crispr/rna-guided nuclease-related methods and compositions for treating rho-associated autosomal-dominant retinitis pigmentosa (adrp)
|
CN115737892B
(zh)
*
|
2022-11-21 |
2024-06-14 |
诺莱生物医学科技有限公司 |
搭载修复基质的弹性敷料及其制备方法
|